Retour sur lavenir.net
   RECTICEL 12.660 € (+1,12 %)     NYXOAH 1.420 € (+1,57 %)     KBC 130.550 € (+0,69 %)     AB INBEV 68.800 € (+0,17 %)     MELEXIS 71.500 € (-1,38 %)     UCB 220.100 € (-0,77 %)     ONTEX GROUP 2.485 € (-0,40 %)     ARGENX SE 758.600 € (-0,32 %)     ELIA GROUP 131.300 € (+0,15 %)     BARCO 7.980 € (+0,38 %)     GBL 75.550 € (-0,26 %)     MONTEA 66.300 € (-0,60 %)     D'IETEREN GROUP 176.000 € (-0,34 %)     VGP 80.800 € (+0,75 %)     UMICORE 23.380 € (-3,47 %)     AEDIFICA 68.200 € (+0,15 %)     BEKAERT 38.100 € (+0,66 %)     GIMV 44.050 € (+0,23 %)     AGEAS 72.775 € (+0,03 %)     SOLVAY 25.960 € (-2,55 %)     DEME GROUP 167.400 € (+0,24 %)     DECEUNINCK 2.220 € (0,00 %)     TUBIZE-FIN 185.700 € (-0,59 %)     XIOR 27.400 € (-0,54 %)     CMB.TECH 14.540 € (+0,97 %)     WDP 21.300 € (-0,37 %)     KBC ANCORA 92.000 € (+0,55 %)     SOFINA 249.400 € (+0,24 %)     COLRUYT 38.440 € (+0,52 %)     EVS 28.350 € (+1,43 %)     SYENSQO 79.600 € (-1,49 %)     SIPEF 96.800 € (+4,42 %)     ACKERMANS V.HAAREN 264.200 € (+0,08 %)     AZELIS GROUP 11.940 € (+0,17 %)     FAGRON 22.300 € (+0,45 %)     LOTUS BAKERIES 12 540.000 € (+1,62 %)     ORANGE BELGIUM 22.000 € (0,00 %)     TITAN S.A. 51.850 € (+1,67 %)     SHURGARD 24.100 € (+1,05 %)     ONWARD MEDICAL 2.405 € (+0,63 %)     IBA 16.080 € (+1,64 %)     TESSENDERLO 21.050 € (-1,17 %)     CENERGY 22.800 € (+2,15 %)     CFE 11.750 € (-2,08 %)     BPOST 1.398 € (0,00 %)     ATENOR 1.280 € (+0,79 %)     VAN DE VELDE 29.700 € (0,00 %)     PROXIMUS 6.250 € (-0,24 %)     NEXTENSA 45.300 € (-2,04 %)     HOME INVEST BE. 19.320 € (-0,31 %)     FLUXYS BELGIUM D 20.300 € (+1,00 %)     NYRSTAR 0.061 € (0,00 %)     VASTNED 28.950 € (-0,34 %)     ECONOCOM GROUP 1.470 € (-1,34 %)     CIE BOIS SAUVAGE 301.000 € (0,00 %)     QRF 10.350 € (0,00 %)     KINEPOLIS GROUP 41.000 € (+0,86 %)     JENSEN-GROUP 72.400 € (-0,55 %)     CARE PROPERTY INV. 12.140 € (-0,16 %)     BREDERODE 103.000 € (0,00 %)  
   EXOSENS 64.250 € (-1,91 %)     OPMOBILITY 12.560 € (+0,64 %)     UBISOFT ENTERTAIN 5.404 € (+3,76 %)     HAFFNER ENERGY 0.636 € (-8,36 %)     VALLOUREC 18.275 € (-0,03 %)     ASM INTERNATIONAL 894.600 € (-0,36 %)     BUREAU VERITAS 27.790 € (+0,18 %)     LVMH 465.200 € (+0,05 %)     ASML HOLDING 1 577.000 € (+0,64 %)     CSG 18.684 € (+1,27 %)     ADYEN 1 076.600 € (+18,31 %)     RENAULT 28.460 € (+0,46 %)     TOTALENERGIES 74.910 € (-0,82 %)     AIRBUS 215.350 € (+0,80 %)     VINCI 122.150 € (-0,93 %)     ATOS GROUP 29.900 € (+0,95 %)     PHARMING GROUP 1.030 € (+2,54 %)     UMG 14.785 € (-0,64 %)     ING GROEP N.V. 31.130 € (+0,74 %)     EXAIL TECHNOLOGIES 124.700 € (-0,08 %)     SCHNEIDER ELECTRIC 310.300 € (-0,23 %)     AXA 44.890 € (+0,36 %)     PHILIPS KON 23.510 € (+1,38 %)     MICHELIN 34.640 € (+0,09 %)     AMG 33.400 € (-1,30 %)     KPN KON 4.042 € (+0,95 %)     GETLINK SE 18.680 € (+0,32 %)     STMICROELECTRONICS 47.300 € (-1,53 %)     SOCIETE GENERALE 83.370 € (+0,30 %)     RANDSTAD NV 38.850 € (+1,12 %)     BNP PARIBAS ACT.A 112.940 € (+0,84 %)     REN 3.555 € (-0,56 %)     VALBIOTIS 0.861 € (+4,74 %)     REXEL 37.860 € (+0,66 %)     SEMCO TECHNOLOGIES 44.050 € (-2,76 %)     APERAM 48.140 € (-1,43 %)     SANOFI 75.660 € (+0,32 %)     FORFARMERS 5.810 € (0,00 %)     NANOBIOTIX 33.820 € (-2,03 %)     ENGIE 26.040 € (+0,27 %)     EIFFAGE 121.100 € (-0,82 %)     SOITEC 132.750 € (+0,80 %)     CELLECTIS 2.840 € (+6,77 %)     L'OREAL 386.100 € (+1,49 %)     SAFRAN 363.000 € (-0,17 %)     TKH GROUP 51.450 € (+5,21 %)     KKO INTERNATIONAL 0.055 € (+3,75 %)     AIR LIQUIDE 169.560 € (-0,46 %)     HERMES INTL 1 596.000 € (-0,44 %)     KALRAY 6.850 € (-0,29 %)     INNATE PHARMA 2.250 € (+3,69 %)     PROSUS 37.940 € (-1,86 %)     AYVENS 11.690 € (+0,09 %)     NEXITY 7.260 € (+1,47 %)     EUTELSAT COMMUNIC. 2.225 € (+2,91 %)     EUROFINS SCIENT. 70.000 € (+0,57 %)     REMY COINTREAU 46.960 € (+1,03 %)     VIVENDI SE 1.629 € (-0,12 %)     ARCHOS 0.265 € (-8,93 %)     TECHNIP ENERGIES 30.580 € (+1,06 %)  
News Réglementées
06/01/2023 14:08

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( )
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

06-Jan-2023 / 13:08 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Vanguard Group, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Mediclinic International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

04 January 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

17,941,316

2.43%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

17,941,316

2.43%

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Sale

41,978

4.97 GBP

10p ordinary

Purchase

11,866

4.97 GBP

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière